Santa Cruz, CA, US • 100 - 249 Employees
BioTech/Drugs
Our platforms use silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules. We will help transform point-of-care testing and third generation sequencing.
BiotechnologyHealthcareBioTech/DrugsCommercial Physical Research